These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9352991)

  • 1. Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure.
    Goldsmith RL; Bigger JT; Bloomfield DM; Krum H; Steinman RC; Sackner-Bernstein J; Packer M
    Am J Cardiol; 1997 Oct; 80(8):1101-4. PubMed ID: 9352991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
    Demopoulos L; Yeh M; Gentilucci M; Testa M; Bijou R; Katz SD; Mancini D; Jones M; LeJemtel TH
    Circulation; 1997 Apr; 95(7):1764-7. PubMed ID: 9107160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol in the treatment of elderly patients with chronic heart failure.
    Witte KK; Clark AL
    Clin Interv Aging; 2008; 3(1):55-70. PubMed ID: 18488879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure.
    Bullinga JR; Alharethi R; Schram MS; Bristow MR; Gilbert EM
    J Card Fail; 2005 Dec; 11(9):693-9. PubMed ID: 16360965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term oral carvedilol in chronic heart failure.
    Di Lenarda A; Sabbadini G; Moretti M; Sinagra G
    Expert Opin Pharmacother; 2004 Jun; 5(6):1359-72. PubMed ID: 15163280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
    Feuerstein G; Ruffolo RR
    Adv Pharmacol; 1998; 42():611-5. PubMed ID: 9327976
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute effects of a single oral dose of carvedilol on cardiac sympathovagal balance in man.
    Haseroth K; Löffler P; Janson CP; Kropff S; Schmidt BM; Feuring M; Christ M; Wehling M
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):315-21. PubMed ID: 11471776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol for heart failure: renewed interest in beta blockers.
    Young JB
    Cleve Clin J Med; 1997 Sep; 64(8):415-22. PubMed ID: 9308217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective evaluation of effect of carvedilol therapy on heart rate variability in patients with dilated cardiomyopathy].
    Hoffmann J; Grimm W; Menz V; Hufnagel G; Maisch B
    Z Kardiol; 1999 Sep; 88(9):653-60. PubMed ID: 10525927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
    Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
    Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure.
    Yildirir A; Sade E; Tokgozoglu L; Oto A
    Eur J Heart Fail; 2001 Dec; 3(6):717-21. PubMed ID: 11738224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gln(27)-->Glubeta(2)-adrenergic receptor polymorphism in heart failure patients: differential clinical and oxidative response to carvedilol.
    Troncoso R; Moraga F; Chiong M; Roldán J; Bravo R; Valenzuela R; Díaz-Araya G; del Campo A; Sanhueza C; Rodriguez A; Vukasovic JL; Mellado R; Greig D; Castro PF; Lavandero S
    Basic Clin Pharmacol Toxicol; 2009 May; 104(5):374-8. PubMed ID: 19422106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of carvedilol alone versus carvedilol + pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group.
    Yoshikawa T; Baba A; Suzuki M; Yokozuka H; Okada Y; Nagami K; Takahashi T; Mitamura H; Ogawa S
    Am J Cardiol; 2000 Jun; 85(12):1495-7; A7. PubMed ID: 10856401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.